Profile data is unavailable for this security.
About the company
Captor Therapeutics SA is a Poland-based biopharmaceutical company, which specializes in the development of drugs that cause the targeted degradation of pathogenic proteins. The Company works in the field of neoplastic and autoimmune diseases for which there is no treatment option, or the available methods show therapeutic limitations. The Company covers aspects of early-stage drug development to deliver therapeutics for life-threatening and life-impairing diseases. The broadly applicable Optigrade tm Targeted Protein Degradation (TPD) platform allows for the creation of new drugs.
- Revenue in PLN (TTM)18.64m
- Net income in PLN-46.69m
- Incorporated2018
- Employees104.00
- LocationCaptor Therapeutics SAul. Dunska 11WROCLAW 54-427PolandPOL
- Websitehttps://www.captortherapeutics.pl/
More ▼